Biocon, Handok ink pact for commercialization of chronic weight management Liraglutide in South Korea Ruchika Sharma24 May 2024 1:30 PM ISTBengaluru: A global biopharmaceutical company, Biocon Limited, has announced the signing of an exclusive licensing and supply agreement...
Biocon Biologics forays into US Ophthalmology market with USFDA nod for Yesafili Ruchika Sharma21 May 2024 11:30 AM ISTBengaluru: Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd, today announced that the U.S....
Biocon net profit declines 57 percent to Rs 136 crore in Q4 Ruchika Sharma20 May 2024 5:45 PM ISTNew Delhi: Biocon, a biotech company has recorded a 57 percent decrease in its consolidated net profit to Rs 136 crore for the fourth...
Biocon, Medix join hands for commercialization of weight management drug Liraglutide in Mexico Ruchika Sharma13 May 2024 12:01 PM ISTBengaluru: Biocon Limited, an innovation-led global biopharmaceutical company, today announced the signing of a semi-exclusive distribution and...
Biocon Limited signs an exclusive licensing and supply agreement for generic Ozempic (Semaglutide) commercialization in Brazil with Biomm S.A. Ruchika Sharma20 April 2024 10:13 AM ISTBiocon, Biomm S.A. ink pact for diabetes drug Semaglutide commercialization in Brazil
Biocon gets MHRA UK nod for weight management injection Liraglutide Ruchika Sharma1 April 2024 2:22 PM ISTBangalore: Biocon Limited, through its European partner, Zentiva, has received approval from the Medicines and Healthcare Products Regulatory...
Biocon obtains approval for diabetes drug Liraglutide in UK Ruchika Sharma28 March 2024 2:30 PM ISTBengaluru: Biocon Limited, a global biopharmaceuticals company, has announced that the Company has received approval from the Medicines and...
Eris Lifesciences acquires Biocon Biologics India branded formulation business for Rs 1242 crore Susmita Roy15 March 2024 1:51 PM ISTMumbai: Eris Lifesciences Ltd., a branded formulations company, has announced the acquisition of Biocon Biologics' India branded formulation...
Biocon Biologics Biocon Campus (Site 1) facility gets 4 USFDA observations Ruchika Sharma1 March 2024 12:01 PM ISTBangalore: Biocon has recently announced that the U.S. Food and Drug Administration (USFDA) has issued Form 483s with 4 observations at...
Biocon receives over Rs 3 crore penalty over GST related issues Ruchika Sharma24 Feb 2024 4:30 PM ISTNew Delhi: Biocon Ltd has said it has been imposed a penalty of over Rs 3 crore over GST-related issues. The company has received an order of...
Biocon registers consolidated revenue of Rs 4519 crore in Q3 Ruchika Sharma9 Feb 2024 4:03 PM ISTBengaluru: Bengaluru, Biocon Ltd, the Bengaluru-based pharmaceutical giant has announced its consolidated financial results for the fiscal third...
Biocon Biologics, Sandoz Australia ink pact for biosimilars Trastuzumab, Bevacizumab Ruchika Sharma9 Feb 2024 12:30 PM ISTTrastuzumab is a biosimilar of Herceptin and Bevacizumab is a biosimilar of Avastin - both biosimilars are available on the PBS and utilised for the...
